[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
[HTML][HTML] Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - cir.nii.ac.jp
抄録< jats: p> Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
(MOGAD) is the most recently defined inflammatory demyelinating disease of the central …
(MOGAD) is the most recently defined inflammatory demyelinating disease of the central …
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.
E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - europepmc.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
E Sechi, L Cacciaguerra, JJ Chen… - Advances in …, 2022 - books.google.com
During the last 15 years, the global concept of inflammatory demyelinating disorders of the
central nervous system (CNS) has radically changed with the identification of specific …
central nervous system (CNS) has radically changed with the identification of specific …
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
E Sechi, L Cacciaguerra, JJ Chen… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
E Sechi, L Cacciaguerra, JJ Chen… - Frontiers in …, 2022 - mayoclinic.elsevierpure.com
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - FRONTIERS IN …, 2022 - iris.univr.it
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
[PDF][PDF] Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Front. Neurol. 13 …, 2022 - iris.univr.it
Sechi et al. MOGAD considered and may be efficacious based on retrospective or
prospective observational studies but prospective randomized placebo-controlled trials are …
prospective observational studies but prospective randomized placebo-controlled trials are …
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
E Sechi, L Cacciaguerra, JJ Chen… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …